Effects of atomoxetine on hyper-locomotive activity of the prenatally valproate-exposed rat offspring.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Chang Soon | - |
dc.contributor.author | Hong, Min ha | - |
dc.contributor.author | Kim, Ki Chan | - |
dc.contributor.author | Kim, Ji-Woon | - |
dc.contributor.author | Yang, Sung Min | - |
dc.contributor.author | Seung, Hana | - |
dc.contributor.author | Ko, Mee Jung | - |
dc.contributor.author | Choi, Dong-Hee | - |
dc.contributor.author | You, Jueng Soo | - |
dc.contributor.author | Shin, Chan Young | - |
dc.contributor.author | Bahn, Geon Ho | - |
dc.date.accessioned | 2022-07-16T03:00:30Z | - |
dc.date.available | 2022-07-16T03:00:30Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2014-09 | - |
dc.identifier.issn | 1976-9148 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/159111 | - |
dc.description.abstract | A substantial proportion of patients with autism spectrum disorder (ASD) display hyperactivity as a comorbid symptom. Exposure to valproic acid (VPA) during pregnancy produces ASD-like core behavioral phenotypes as well as hyperactivity in offspring both in human and experimental animals, which makes it a plausible model to study ASD-related neurobiological processes. In this study, we examined the effects of two of currently available attention defecit hyperactivity disorder (ADHD) medications, methylphenidate (MPH) and atomoxetine (ATX) targeting dopamine and norepinephrine transporters (DAT and NET), respectively, on hyperactive behavior of prenatally VPA-exposed rat offspring. In the prefrontal cortex of VPA exposed rat offspring, both mRNA and protein expression of DAT was increased as compared with control. VPA function as a histone deacetylase inhibitor (HDACi) and chromatin immunoprecipitation experiments demonstrated that the acetylation of histone bound to DAT gene promoter was increased in VPA-exposed rat offspring suggesting epigenetic mechanism of DAT regulation. Similarly, the expression of NET was increased, possibly via increased histone acetylation in prefrontal cortex of VPA-exposed rat offspring. When we treated the VPA-exposed rat offspring with ATX, a NET selective inhibitor, hyperactivity was reversed to control level. In contrast, MPH that inhibits both DAT and NET, did not produce inhibitory effects against hyperactivity. The results suggest that NET abnormalities may underlie the hyperactive phenotype in VPA animal model of ASD. Profiling the pharmacological responsiveness as well as investigating underlying mechanism in multiple models of ASD and ADHD may provide more insights into the neurobiological correlates regulating the behavioral abnormalities. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC APPLIED PHARMACOLOGY | - |
dc.title | Effects of atomoxetine on hyper-locomotive activity of the prenatally valproate-exposed rat offspring. | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hong, Min ha | - |
dc.identifier.doi | 10.4062/biomolther.2014.027 | - |
dc.identifier.scopusid | 2-s2.0-84908031101 | - |
dc.identifier.wosid | 000342856200005 | - |
dc.identifier.bibliographicCitation | BIOMOLECULES & THERAPEUTICS, v.22, no.5, pp.406 - 413 | - |
dc.relation.isPartOf | BIOMOLECULES & THERAPEUTICS | - |
dc.citation.title | BIOMOLECULES & THERAPEUTICS | - |
dc.citation.volume | 22 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 406 | - |
dc.citation.endPage | 413 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.identifier.kciid | ART001915272 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | - |
dc.subject.keywordPlus | DEFICIT HYPERACTIVITY DISORDER | - |
dc.subject.keywordPlus | PERVASIVE DEVELOPMENTAL DISORDERS | - |
dc.subject.keywordPlus | TRANSPORTER KNOCKOUT MICE | - |
dc.subject.keywordPlus | AUTISM SPECTRUM DISORDERS | - |
dc.subject.keywordPlus | ANIMAL-MODEL | - |
dc.subject.keywordPlus | DOPAMINE TRANSPORTER | - |
dc.subject.keywordPlus | PREFRONTAL CORTEX | - |
dc.subject.keywordPlus | PSYCHIATRIC-DISORDERS | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordAuthor | Valproic acid | - |
dc.subject.keywordAuthor | Autism | - |
dc.subject.keywordAuthor | Hyperactivity | - |
dc.subject.keywordAuthor | Norepinephrine transporter | - |
dc.subject.keywordAuthor | Atomoxetine | - |
dc.identifier.url | https://www.biomolther.org/journal/view.html?volume=22&number=5&spage=406&year=2014 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.